City

New York (2)

Aurora (1)

Boston (1)

Cleveland (1)

Houston (1)

Los Angeles (1)

Perth (1)

Philadelphia (1)

Saint Louis (1)

Condition

CDD (2)

CDKL5 (1)

CDKL5 Deficiency Disorder (1)

Overall Status

Enrolling by invitation (1)

Recruiting (1)

Phase

phase 2 (1)

Sponsor

NYU Langone Health (1)

University of Colorado, Denver (1)

Collaborator

International Foundation for CDKL5 Research (1)

National Institute of Neurological Disorders and Stroke (NINDS) (1)

National Institutes of Health (NIH) (1)

Intervention

fenfluramine hydrochloride (1)

no intervention. (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

cdd

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

International CDKL5 Clinical Research Network

Recruiting

CDKL5
+2 more

No intervention.

Los Angeles, California
+8 more

Sep 23, 2022

CDD Trial in New York (Fenfluramine Hydrochloride)

Enrolling by invitation

Fenfluramine Hydrochloride

New York, New York

New York Langone Health Comprehensive Epilespy Center

Apr 5, 2022